Potential of general practice data for congenital anomaly research: Comparison with registry data in the United

Rachel Sokal1, Kate M Fleming, Laila J Tata

  • 1Division of Epidemiology and Public Health, University of Nottingham, Nottingham, United Kingdom. mcxrs7@nottingham.ac.uk

Insights

The Health Improvement Network (THIN) database shows congenital anomaly (CA) prevalence similar to registries like EUROCAT for early diagnoses. Including later diagnoses improves CA detection in primary care data.

Area of Science:

  • Epidemiology
  • Public Health
  • Medical Informatics

Background:

  • General practice databases offer large, prospectively collected medical information for studying congenital anomalies (CAs).
  • Validation of these data against established CA registries is crucial for their reliable use.

Purpose of the Study:

  • To validate the utility of The Health Improvement Network (THIN) primary care database for studying congenital anomalies (CAs).
  • To compare CA prevalence data from THIN with established European Surveillance of Congenital Anomalies (EUROCAT) registries.

Main Methods:

  • Utilized data from 794,209 children in the THIN database born between 1990-2009.
  • Compared birth prevalence of major and system-specific CAs in THIN with EUROCAT UK registries.

Main Results:

  • THIN showed a birth prevalence of major CAs (diagnosed before 1 year) of 198/10,000, slightly higher than EUROCAT's 167/10,000.
  • Small absolute prevalence differences were observed across 16 system-specific anomaly groups.
  • Including diagnoses made after 1 year of age increased THIN's overall major CA prevalence to 277/10,000.

Conclusions:

  • THIN data are consistent with EUROCAT for early congenital anomaly diagnoses, confirming THIN as a valuable data source.
  • The age of diagnosis significantly impacts overall CA prevalence figures in primary care databases.
  • Incorporating diagnoses made after the first year of life enhances the capture of congenital anomalies in population-based studies.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Behavioral Genetics and Its Designs01:23

Behavioral Genetics and Its Designs

Behavior genetics explores how genetic inheritance influences human behavior. It focuses on how genes, passed from parents to offspring, contribute to the development of behavioral traits and tendencies. This branch of genetics seeks to understand the complex interplay between inherited genetic factors and environmental influences in shaping our behaviors.
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...